Partnerships

MustGrow Biologics Signs 5-Year Exclusive Distribution Agreement with Adjuvants Plus

MustGrow Biologics Corp. announces receipt of The State of Oregon Agriculture Fertilizer Registration Certificate for TerraSanteTM, expanding its market reach.

Key Takeaways

  • MustGrow Biologics Corp. has signed a five-year exclusive distribution agreement with Adjuvants Plus Inc.
  • MustGrow will distribute Adjuvants’ product line in Canada through its NexusBioAg division.
  • The agreement includes a First Right of Refusal for U.S. distribution.
  • EndoFine® and EndoGuard® are key products featuring Clonostachys rosea, a beneficial fungus for plant health.
  • MustGrow aims to launch these biological products for the 2025 crop year.

MustGrow Expanding Biological Agriculture Offerings

MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0), a provider of biological and regenerative agriculture solutions, has entered into an exclusive five-year distribution agreement with Adjuvants Plus Inc., a Canadian regenerative agriculture company. The agreement, signed on February 4, 2025, allows MustGrow to distribute Adjuvants’ product line in Canada through NexusBioAg, its recently acquired sales and distribution division. Additionally, MustGrow has secured a First Right of Refusal for potential expansion into the U.S. market.

This marks the first product line addition for NexusBioAg since MustGrow’s acquisition in December 2024.


Innovative Biological Solutions for North American Farmers

Under the agreement, MustGrow will introduce four key products, with a particular focus on EndoFine® and EndoGuard®, which are designed to support various crops, including:

  • Row crops: Corn, soybean, edible beans, pulses, canola, cereals (wheat, barley, oats, rye)
  • Fruits & vegetables: Potatoes and other high-value crops

These products utilize Clonostachys rosea, a patented microbial technology that provides plant health benefits and protection. Extensive trials conducted through NexusBioAg’s BioAdvantage Trials Program (BAT Program) over the past two years have demonstrated significant yield increases across multiple crops in Canada.

Regulatory approvals are already in place, enabling MustGrow to launch these products for the 2025 crop year in Canada while initiating U.S. trials in fruits and vegetables, particularly targeting California growers.


Product Launch and Market Strategy

The launch of EndoFine® and EndoGuard® will be supported by a comprehensive marketing campaign, targeting:

  • Farmers
  • Retailers
  • Agricultural professionals across Canada

Leadership Perspectives on the Partnership From MustGrow & Adjuvants

Corey Giasson, President & CEO of MustGrow, emphasized the alignment between the two companies’ missions: “Partnering with Adjuvants aligns perfectly with our vision of advancing sustainable agriculture and providing farmers with innovative biological solutions. Through NexusBioAg, our sales and distribution division, we look forward to bringing these solutions to the market and strengthening our relationships with growers across Canada and potentially into the U.S.”

Bill Brown, President of Adjuvants, highlighted the potential impact of the partnership: “Leveraging MustGrow’s distribution platform allows us to bring the benefits of EndoFine® and EndoGuard® to more farmers across Canada. With a shared commitment to regenerative agriculture, we are confident that these biological solutions will provide long-term benefits to soil health and crop productivity.”

administrator
As a dedicated journalist and entrepreneur, I helm iGrow News, a pioneering media platform focused on the evolving landscape of Agriculture Technology. With a deep-seated passion for uncovering the latest developments and trends within the agtech sector, my mission is to deliver insightful, unbiased news and analysis. Through iGrow News, I aim to empower industry professionals, enthusiasts, and the broader public with knowledge and understanding of technological advancements that shape modern agriculture. You can follow me on LinkedIn & Twitter.

Leave a Reply